View of Immunotoxicity of Pembrolizumab in patients with metastatic non-small cell lung cancer: A single-centre study

Return to Article Details Immunotoxicity of Pembrolizumab in patients with metastatic non-small cell lung cancer: A single-centre study Download Download PDF